Welcome to the 5th Annual Gene Therapy Analytical Development Summit 2023
Develop, Validate & Implement Robust Analytical Tools to Guarantee Safety, Efficacy, Quality, & Consistency of Gene Therapy Products
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.
In this context, the 5th Annual Gene Therapy Analytical Development is returning in 2023, uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality, consistency, safety, and efficacy of gene therapy products.
Join biopharma colleagues specializing in bioassays, molecular biology, physicochemical properties, quality, process development and regulation across 4 days of niche, expert presentations, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer, efficacious therapies to patients more quickly and effectively.
Previously Attending Companies Include:
World-Class Speaker Faculty Includes:
Associate Director, Gene Therapy Analytical Development
Associate Director, Group Leader
Associate Director, Analytical & Biophysical Development
Senior Director, Analytical Development, Cell & Gene Therapy
Quality , Cells, Gene Therapies & Radiopharmaceuticals Division Evaluator
Senior Scientist, AAV Pharmaceutical Development
BridgeBio Gene Therapy
Analytical Program Development and Management
Executive Director, Analytical Development & Quality Control
“GTAD was my favorite conference I attended all last year by far! It strikes a great balance between broadness and the topics being narrow enough that all attendees are very engaged. As an attendee this means all the talks are interesting and relevant to my work. As a speaker this means an engaged audience with insightful questions and valuable feedback.”
2022 Attendee, Sanofi
2023 Senior Partners:
Download the Full Event Guide for more information on:
- Expert Speaker Faculty
- Full Access to the 4-Day Conference Agenda
- Audience Breakdown
- & more